{"id":384630,"date":"2025-09-12T06:24:14","date_gmt":"2025-09-12T06:24:14","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/384630\/"},"modified":"2025-09-12T06:24:14","modified_gmt":"2025-09-12T06:24:14","slug":"deux-nouveaux-vaccins-recommandes-aux-seniors-cette-annee","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/384630\/","title":{"rendered":"deux nouveaux vaccins recommand\u00e9s aux s\u00e9niors cette ann\u00e9e"},"content":{"rendered":"<p>    Les plus de 65 ans sont particuli\u00e8rement expos\u00e9s aux formes graves de la maladie. L\u2019an dernier, 92% des d\u00e9c\u00e8s sont survenus au sein de cette population.<br \/>\n                thodonal &#8211; stock.adobe.com<\/p>\n<p>Pour la campagne vaccinale qui d\u00e9butera en octobre, les autorit\u00e9s sanitaires appellent \u00e0 privil\u00e9gier chez les plus de 65 ans deux vaccins mieux \u00e0 m\u00eame de les prot\u00e9ger face aux virus de la grippe. Quelles sont les particularit\u00e9s de Fluad et Efluelda\u00a0?<\/p>\n<p class=\"fig-paragraph\">Comme tous les ans,\u00a0<a href=\"http:\/\/sante.lefigaro.fr\/medecine\/la-campagne-de-vaccination-contre-la-grippe-et-le-covid-commencera-le-14-octobre-prochain-20250910\" data-fig-type=\"Article\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"SANTE\" target=\"_blank\" rel=\"noopener\">une nouvelle campagne vaccinale<\/a>\u00a0contre la\u00a0<a href=\"https:\/\/sante.lefigaro.fr\/sante\/maladie\/grippe\/quelles-differences-entre-grippes-b\" target=\"_blank\" data-fig-type=\"Keyword\" rel=\"sponsored noopener\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"SANTE\">grippe<\/a>\u00a0va d\u00e9marrer mi-octobre, alors que l\u2019hiver et la recrudescence des virus saisonniers s\u2019annoncent. Et deux nouveaux vaccins sont au menu du mill\u00e9sime 2025-2026\u00a0: la Haute Autorit\u00e9 de sant\u00e9 (HAS) a choisi de mettre en avant deux vaccins,\u00a0<a href=\"http:\/\/sante.lefigaro.fr\/social\/sante-publique\/grippe-le-vaccin-a-haute-dose-efluelda-de-retour-pour-l-hiver-prochain-20250724\" data-fig-type=\"NewsFlash\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\" data-fig-domain=\"SANTE\" target=\"_blank\" rel=\"noopener\">Efluelda<\/a>\u00a0et Fluad, chez les plus de 65 ans. La population la plus expos\u00e9e aux complications graves de la maladie.<\/p>\n<p class=\"fig-paragraph\"><a href=\"https:\/\/www.has-sante.fr\/jcms\/p_3604446\/fr\/vaccination-contre-la-grippe-saisonniere-des-personnes-de-65-ans-et-plus-place-des-vaccins-efluelda-et-fluad\" target=\"_blank\" rel=\"sponsored noopener\" data-gtm-custom-categorie=\"navigation\" data-gtm-custom-action=\"crossclick\" data-gtm-custom-label=\"Contextuel\" data-gtm-event=\"customEventSPE\">Dans un avis publi\u00e9 le 9 mai<\/a>, l\u2019institution pr\u00e9conisait que \u00ab\u00a0ces vaccins adjuvant\u00e9s et hautement dos\u00e9s soient utilis\u00e9s pr\u00e9f\u00e9rentiellement dans cette tranche d\u2019\u00e2ge\u00a0\u00bb, tout en maintenant la possibilit\u00e9 d\u2019utiliser les vaccins \u00e0 dose standard (Influvac, Vaxigrip et Flucelvax) lorsque les premiers ne sont pas disponibles. Une \u00e9volution qui alignera la France sur les recommandations internationales et sur les pratiques d\u00e9j\u00e0 mises en \u0153uvre aux \u00c9tats-Unis ou au Canada notamment. Quels atouts ont conduit ces vaccins \u00e0 figurer au calendrier vaccinal pour la campagne qui d\u00e9butera\u2026<\/p>\n<p class=\"fig-premium-paywall__infos\">\n        Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s.        Il vous reste 81% \u00e0 d\u00e9couvrir.\n    <\/p>\n<p>                <img  data- alt=\"Le Figaro\" class=\"fig-img--complete fig-img\"\/><\/p>\n<p class=\"fig-premium-paywall__title\">Vous avez envie de lire la suite ?<\/p>\n<p class=\"fig-premium-paywall__subtitle\">D\u00e9bloquez tous les articles imm\u00e9diatement.<\/p>\n<p class=\"fig-premium-paywall__connect\">\n                D\u00e9j\u00e0 abonn\u00e9\u00a0?                <a class=\"fig-premium-paywall__connect-link\" href=\"https:\/\/connect.lefigaro.fr\/login?client=sante_web&amp;type=main&amp;redirect_uri=https%3A%2F%2Fsante.lefigaro.fr%2Fmedecine%2Fgrippe-deux-nouveaux-vaccins-recommandes-aux-seniors-cette-annee-20250912\" data-js-gtm=\"{&quot;customCategorie&quot;: &quot;conversion&quot;, &quot;customAction&quot;: &quot;before_Landing_Connexion_paywall_auto&quot;, &quot;customLabel&quot;: &quot;c2FudGUubGVmaWdhcm8uZnJfXzFmMDhlZjg4LTI0MzQtNjIyNC1iZjZhLTM5MGJjYWYwNjZmNV9fQXJ0aWNsZQ==_Grippe\u00a0: deux nouveaux vaccins recommand\u00e9s aux s\u00e9niors cette ann\u00e9e_578&quot;, &quot;customIDSPE&quot;: &quot;c2FudGUubGVmaWdhcm8uZnJfXzFmMDhlZjg4LTI0MzQtNjIyNC1iZjZhLTM5MGJjYWYwNjZmNV9fQXJ0aWNsZQ==&quot;, &quot;event&quot;: &quot;customEventSPE&quot;}\" target=\"_blank\" rel=\"noopener\"><br \/>\n                    Connectez-vous<br \/>\n                <\/a>\n            <\/p>\n","protected":false},"excerpt":{"rendered":"Les plus de 65 ans sont particuli\u00e8rement expos\u00e9s aux formes graves de la maladie. L\u2019an dernier, 92% des&hellip;\n","protected":false},"author":2,"featured_media":384631,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[11,1011,27,29786,12,25,773],"class_list":{"0":"post-384630","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-actualites","8":"tag-actualites","9":"tag-fr","10":"tag-france","11":"tag-grippe","12":"tag-news","13":"tag-republique-francaise","14":"tag-vaccin"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115189898746060886","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/384630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=384630"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/384630\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/384631"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=384630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=384630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=384630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}